Australia markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
115.00+3.55 (+3.19%)
At close: 04:00PM EST
114.00 -1.00 (-0.87%)
After hours: 07:31PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.25B
Enterprise value 1.21B
Trailing P/E 8.69
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.80
Price/book (mrq)8.33
Enterprise value/revenue 0.74
Enterprise value/EBITDA 5.77

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-38.05%
S&P500 52-week change 3-8.00%
52-week high 3200.82
52-week low 396.00
50-day moving average 3118.26
200-day moving average 3141.39

Share statistics

Avg vol (3-month) 3141.12k
Avg vol (10-day) 3166.92k
Shares outstanding 510.93M
Implied shares outstanding 6N/A
Float 810.02M
% held by insiders 11.99%
% held by institutions 190.64%
Shares short (12 Jan 2023) 4589.47k
Short ratio (12 Jan 2023) 44.98
Short % of float (12 Jan 2023) 48.20%
Short % of shares outstanding (12 Jan 2023) 45.39%
Shares short (prior month 14 Dec 2022) 4635.46k

Dividends & splits

Forward annual dividend rate 46.56
Forward annual dividend yield 45.70%
Trailing annual dividend rate 36.34
Trailing annual dividend yield 35.69%
5-year average dividend yield 42.76
Payout ratio 447.99%
Dividend date 306 Feb 2023
Ex-dividend date 418 Dec 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 9.22%
Operating margin (ttm)12.14%

Management effectiveness

Return on assets (ttm)35.66%
Return on equity (ttm)87.13%

Income statement

Revenue (ttm)1.64B
Revenue per share (ttm)144.19
Quarterly revenue growth (yoy)-5.60%
Gross profit (ttm)1.13B
EBITDA 210.12M
Net income avi to common (ttm)151.07M
Diluted EPS (ttm)13.21
Quarterly earnings growth (yoy)-13.90%

Balance sheet

Total cash (mrq)69.71M
Total cash per share (mrq)6.42
Total debt (mrq)27.7M
Total debt/equity (mrq)18.40
Current ratio (mrq)1.49
Book value per share (mrq)13.85

Cash flow statement

Operating cash flow (ttm)135.37M
Levered free cash flow (ttm)101.15M